Creatine corrects muscle 31P spectrum in gyrate atrophy with hyperornithinaemia

European Journal of Clinical Investigation

Volumn 29, Issue 12, 1999, Pages 1060-1065

  Heinanen K ^a   Nanto Salonen K ^a   Komu, M ^a   Erkintalo, M ^a   Alanen, A ^a   Heinonen, O J ^a,b   Pulkki, K ^b   Nikoskelainen, E ^a   Sipila I ^c   Simell, O ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Creatine phosphate; Gyrate atrophy of the choroid and retina; Hyperornithinaemia; Magnetic resonance spectroscopy; Muscle

Indexed keywords

CREATINE; CREATINE PHOSPHATE; GUANIDINOACETIC ACID; METHIONINE; ORNITHINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERORNITHINEMIA; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RETINA GYRATE ATROPHY;

ADOLESCENT; ADULT; CHILD; CREATINE; DIETARY SUPPLEMENTS; FEMALE; GLYCINE; GYRATE ATROPHY; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METHIONINE; MIDDLE AGED; MUSCLE, SKELETAL; ORNITHINE; PHOSPHORUS ISOTOPES;

EID: 0032724358     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00569.x     Document Type: Article

References (27)

1. Simell O, Takki K. Raised plasma ornithine and gyrate atrophy of the choroid and retina. Lancet 1973;1:1031-3.
2. Trijbels JMF, Sengers RCA, Bakkeren JAJM, de Kort AFM, Deutman AF. L-ornithine-ketoacid-transferase deficiency in cultured fibroblasts of a patient with hyperornithinaemia and gyrate atrophy of the choroid and retina. Clin Chim Acta 1977;79:371-7.
3. Valle D, Simell O. The hyperornithinaemias. In: Scriver CR, Beaudet AL, Sly WS & Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease New York: McGraw-Hill; 1995. p. 1147-85.
4. Kaiser-Kupfer MI, Kuwabara T, Askanas V et al. Systemic manifestations of gyrate atrophy of the choroid and retina. Ophthalmology 1981;88:302-6.
5. Sipilä I, Simell O, Rapola J, Sainio K, Tuuteri L. Gyrate atrophy of the choroid and retina: Tubular aggregates and type 2 fiber atrophy in muscle. Neurology 1979;29:996-1005.
6. Valtonen M, Näntö-Salonen K, Heinänen K, Alanen A, Kalimo K, Simell O. Skeletal muscle of patients with gyrate atrophy of the choroid and retina and hyperornithinaemia in ultralow-field magnetic resonance imaging and computed tomography. J Inherit Metab Dis 1996;19:729-34.
7. Sipilä I. Inhibition of arginine-glycine amidinotransferase by ornithine. Biochim Biophys Acta 1980;613:79-84.
8. Sipilä I, Simell O, Arjomaa P. Gyrate atrophy of the choroid and retina with hyperornithirmemia. Deficient formation of guanidinoacetic acid from ornithine. J Clin Invest 1980;66:684-7.
9. Heinänen K, Näntö-Salonen K, Komu M et al. Muscle creatine phosphate in gyrate atrophy of the choroid and retina with hyperornithinaemia - clues to pathogenesis. Eur J Clin Invest 1999;29:426-31.
10. Hultman E, Söderlund K, Timmons JA, Cederblad G, Greenhaff PL. Muscle creatine loading in men. J Appl Physiol 1996;81:232-7.
11. Wakatsuki T, Ohira Y, Yasui W et al. Responses of contractile properties in rat soleus to high-energy phosphates and/or unloading. Jpn J Physiol 1994;44:193-204.
12. Greenhaff PL, Bodin K, Soderlund K, Hultman E. Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis. Am J Physiol 1994;266:E725-30.
13. Guerrero-Ontiveros ML, Wallimann T: Crcatine supplementation in health and disease. Effects of chronic creatine ingestion in vivo: down-regulation of the expression of creatine transporter isoforms in skeletal muscle. Mol Cell Biochem 1998;184:427-37.
14. Stöckler S, Holzbach U, Hanefeld F et al. Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Ped Res 1994;36:409-13.
15. Stöckler S, Hanefeld F, Frahm J. Creatine replacement therapy in guainidinoacetate methyltransferase deficiency, a novel inborn error of metabolism. Lancet 1996;348:789-90.
16. Ganesan V, Johnson A, Connely A, Eckhardt S, Surtees R. Guanidinoacetate methyltransferase deficiency: new clinical features. Pediatr Neurol 1997;17:155-7.
17. Sipilä T, Rapola J, Simell O, Vannas A. Supplementary creatine as a treatment for gyrate atrophy of the choroid and retina. N Engl J Med 1981;304:867-70.
18. Vannas-Sulonen K, Sipilä I, Vannas A, Simell O, Rapola J. Gyrate atrophy of the choroid and retina. A five-year follow-up of creatine supplementation. Ophthalmology 1985;92:1719-27.
19. Walker JB. Creatine: biosynthesis, regulation, and function. Adv Enzymol 1979;50:177-242.
20. 31P NMR study. Proc Natl Acad Sci USA 1981;78:6714-8.
21. Sahlin K. Control of energetic processes in contracting human skeletal muscle. Biochim Soc Trans 1991;19:353-8.
22. 31P MRS of human skeletal muscle. In: de Certaines JD, Bovee WMMJ & Podo F, editors, Magnetic Resonance Spectroscopy in Biology and Medicine Oxford: Pergamon Press; 1992.p. 369-86.
23. i. Proc Natl Acad Sci USA 1992;89:7521-5.
24. Vandenborne K, Walter G, Ploutz-Snyder L et al. Energy-rich phosphates in slow and fast human skeletal muscle. Am J Physiol 1995;268:C869-76.
25. Näntö-Salonen K, Komu M, Lundbom N et al. Reduced brain creatine in gyrate atrophy of the choroid and retina with hyperornithinemia. Neurology 1999;53:303-7.
26. Loike JD, Zalutsky DL, Kaback E, Miranda AF, Silverstein SC. Extracellular creatine regulates creatine transport in rat and human muscle cells. Proc Natl Acad Sci USA 1988;85:807-11.
27. Möller A, Hamprecht B. Creatine transport in cultured cells of rat and mouse brain. J Neurochem 1989;52:544-50.